PREVENTIVES/REMEDIES FOR STRESS URINARY INCONTINENCE AND METHOD OF SCREENING THE SAME
申请人:Takeda Pharmaceutical Company Limited
公开号:EP1792629A1
公开(公告)日:2007-06-06
An agent for the prophylaxis or treatment of stress urinary incontinence, which contains a substance that activates a serotonin 5-HT2C receptor, an agent for the prophylaxis or treatment of stress urinary incontinence, which contains a substance that stimulates an androgen binding site, and a method of screening for a drug for the prophylaxis or treatment of abdominal pressure incontinence, which includes electrostimulating the abdominal muscles or a nerve controlling them of an animal to increase the abdominal pressure, and measuring the leak point pressure at that time.
一种预防或治疗压力性尿失禁的药物,其中含有一种能激活5-羟色胺5-HT2C受体的物质;一种预防或治疗压力性尿失禁的药物,其中含有一种能刺激雄激素结合位点的物质、以及一种筛选预防或治疗腹压性尿失禁药物的方法,其中包括电刺激动物的腹部肌肉或控制腹部肌肉的神经以增加腹压,并测量当时的漏点压力。